p53 Predictive Value for pT1-2 N0 Disease at Radical Cystectomy

Journal of Urology

Volumn 182, Issue 3, 2009, Pages 907-913

  Shariat, Shahrokh F ^a   Lotan, Yair ^a   Karakiewicz, Pierre I ^c   Ashfaq, Raheela ^a   Isbarn, Hendrik ^c   Fradet, Yves ^d   Bastian, Patrick J ^f   Nielsen, Matthew E ^g   Capitanio, Umberto ^c,h   Jeldres, Claudio ^c   Montorsi, Francesco ^h   Müller, Stefan C ^f   Karam, Jose A ^a   Heukamp, Lukas C ^f   Netto, George ^g   Lerner, Seth P ^b   Sagalowsky, Arthur I ^a   Cote, Richard J ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF BONN   (Germany)

^g JOHNS HOPKINS HOSPITAL   (United States)

^h VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

carcinoma; genes; mortality; p53; urinary bladder; urothelium

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 68149179652     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.05.024     Document Type: Article

References (20)

1. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19 (2001) 666
2. Shariat S.F., Palapattu G.S., Karakiewicz P.I., et al. Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy. Eur Urol 51 (2007) 137
3. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307
4. Cote R.J., Dunn M.D., Chatterjee S.J., et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 58 (1998) 1090
5. Sarkis A.S., Dalbagni G., Cordon-Cardo C., et al. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Natl Cancer Inst 85 (1993) 53
6. Serth J., Kuczyk M.A., Bokemeyer C., et al. p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer 71 (1995) 201
7. Chatterjee S.J., Datar R., Youssefzadeh D., et al. Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol 22 (2004) 1007
8. Shariat S.F., Ashfaq R., Sagalowsky A.I., et al. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis. Hum Pathol 37 (2006) 1568
9. Esrig D., Elmajian D., Groshen S., et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331 (1994) 1259
10. Cote R.J., Esrig D., Groshen S., et al. p53 and treatment of bladder cancer. Nature 385 (1997) 123
11. Malats N., Bustos A., Nascimento C.M., et al. P53 as a prognostic marker for bladder cancer: a meta-analysis and review. Lancet Oncol 6 (2005) 678
12. Shariat S.F., Zlotta A.R., Ashfaq R., et al. Cooperative effect of cell-cycle regulators expression on bladder cancer development and biologic aggressiveness. Mod Pathol 20 (2007) 445
13. George B., Datar R.H., Wu L., et al. p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer. J Clin Oncol 25 (2007) 5352
14. Shariat S.F., Karakiewicz P.I., Palapattu G.S., et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol 176 (2006) 2414
15. Shariat S.F., Tokunaga H., Zhou J., et al. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 22 (2004) 1014
16. Lerner S.P. Bladder cancer clinical trials. Urol Oncol 23 (2005) 275
17. Margulis V., Shariat S.F., Ashfaq R., et al. Ki-67 is an independent predictor of bladder cancer outcome in patients treated with radical cystectomy for organ-confined disease. Clin Cancer Res 12 (2006) 7369
18. Karam J.A., Lotan Y., Karakiewicz P.I., et al. Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol 8 (2007) 128
19. Shariat S.F., Ashfaq R., Karakiewicz P.I., et al. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality. Cancer 109 (2007) 1106
20. Shariat S.F., Karakiewicz P.I., Ashfaq R., et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 112 (2008) 315